Tumor-infiltrating immune cells and HLA class I expression as potential predictive markers of immune checkpoint inhibitor therapy

Help

Back »

Details of project

Identifier

128524

Type

ANN

Principal investigator

Ladányi, Andrea

Title in Hungarian

Tumorinfiltráló immunsejtek és HLA I-expresszió szerepének vizsgálata az immunellenőrzőpont-gátló terápiák hatásosságának megjóslásában

Title in English

Tumor-infiltrating immune cells and HLA class I expression as potential predictive markers of immune checkpoint inhibitor therapy

Keywords in Hungarian

immunellenőrzőpont-gátlók; immunterápia; biomarker; melanóma; fej-nyaki daganat; tripla-negatív emlőrák

Keywords in English

immune checkpoint inhibitors; immunotherapy; biomarker; melanoma; head and neck cancer; triple-negative breast cancer

Discipline

Cancer and its biological basis (Council of Medical and Biological Sciences)	70 %
Ortelius classification: Oncology
Immunology (Council of Medical and Biological Sciences)	30 %
Ortelius classification: Immunology

Panel

Immunity, Cancer and Microbiology

Department or equivalent

Sebészeti és Molekuláris Patológiai Osztály (National Institute of Oncology)

Participants

Balatoni, Tímea
Hegyi, Barbara
Herczeg, Adrienn
Hitre, Erika
Horváth, Zsolt
Liszkay, Gabriella
Mohos, Anita
Plotár, Vanda
Remenár, Éva
Székely, Borbála
Tóth, Erika

Starting date

2018-12-01

Closing date

2024-06-30

Funding (in million HUF)

22.472

FTE (full time equivalent)

11.15

state

running project